Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lost in translation: can we afford to miss the trees for the forest?

Literature DB >> 24980775

Lost in translation: can we afford to miss the trees for the forest?

Stephen R Hammes¹, Carol A Lange.

Abstract

Mesh：

Year: 2014 PMID： 24980775 DOI： 10.1007/s12672-014-0187-9

Source DB: PubMed Journal: Horm Cancer ISSN： 1868-8497 Impact factor: 3.869

× No keyword cloud information.

20 in total

1. The Nobel chronicles. 1978: Werner Arber (b 1929); Hamilton O Smith (b 1931); Daniel Nathans (b 1928).

Authors: T N Raju
Journal: Lancet Date: 1999-10-30 Impact factor: 79.321

2. How restriction enzymes became the workhorses of molecular biology.

Authors: Richard J Roberts
Journal: Proc Natl Acad Sci U S A Date: 2005-04-19 Impact factor: 11.205

3. Cloning of the human oestrogen receptor cDNA.

Authors: S Green; P Walter; G Greene; A Krust; C Goffin; E Jensen; G Scrace; M Waterfield; P Chambon
Journal: J Steroid Biochem Date: 1986-01 Impact factor: 4.292

4. Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.

Authors: H W Ward
Journal: Br Med J Date: 1973-01-06

5. Tamoxifen and contralateral breast cancer.

Authors: J Cuzick; M Baum
Journal: Lancet Date: 1985-08-03 Impact factor: 79.321

6. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Authors: Trevor J Powles; Sue Ashley; Alwynne Tidy; Ian E Smith; Mitch Dowsett
Journal: J Natl Cancer Inst Date: 2007-02-21 Impact factor: 13.506

7. Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.

Authors: Kimberly L Blackwell; Harold J Burstein; Anna Maria Storniolo; Hope Rugo; George Sledge; Maria Koehler; Catherine Ellis; Michelle Casey; Svetislava Vukelja; Joachim Bischoff; Jose Baselga; Joyce O'Shaughnessy
Journal: J Clin Oncol Date: 2010-02-01 Impact factor: 44.544

Lost in translation: can we afford to miss the trees for the forest?

1. The Nobel chronicles. 1978: Werner Arber (b 1929); Hamilton O Smith (b 1931); Daniel Nathans (b 1928).

2. How restriction enzymes became the workhorses of molecular biology.

3. Cloning of the human oestrogen receptor cDNA.

4. Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.

5. Tamoxifen and contralateral breast cancer.

6. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

7. Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.

8. Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species.

Review 9. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.

10. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.

1. Editorial: The Future of Our Basic Science and Scientists.